SelectScience
Join Free
Accelerating Science
NewsLife Sciences

Hitachi to support researches in infectious diseases through the Hitachi Global Foundation

Hitachi High Technologies America, Inc.

This support will contribute to the measures against COVID-19, following provision of medical equipment and supplies, employee donations, and loans through NPO

22 Jul 2020
Sophie Ball
Publishing / Media

Industry news

Hitachi, Ltd. has announced that it will donate 100 million yen to The Hitachi Global Foundation to support researches on Novel Coronavirus (COVID-19) and other infectious diseases, and will also solicit donations from Hitachi executive officers and corporate officers (the executive positions next to Executive Officers) to the Hitachi Global Foundation.

The Hitachi Global Foundation will use the funds to launch "The Hitachi Global Foundation Fund for Research Support of Infectious Diseases (tentative)", which will provide support to researchers of universities and research institutions in Japan and ASEAN. The targeted areas are the development of pioneering and applied medical technologies for the prevention, diagnosis, and treatment of infectious diseases such as COVID-19, and the researches contributing to building a new social system for pandemic preparedness. The Hitachi Global Foundation will decide on the details of the scheme, and after the necessary procedures and approvals, the fund will be established and will begin accepting applications in fiscal 2021.

The Hitachi Group is taking steps to prevent the spread of the outbreak, placing top priority on the health and safety of its employees and their families worldwide, as well as its stakeholders, customers, and partners. Subsequently, the Hitachi Group is making maximum efforts to ensure an environment in which business can be conducted through remote working, whilst continuing to support our customers and maintain the functions of critical social infrastructure.

Hitachi Group's supports related to COVID-19
A total of approximately 5 million yuan worth of donations, including a Supria 16 (5M) computed tomography (CT) machine, as well as donations and medical supplies in China.

  • Provision free of charge on face shields (8,000 to 10,000 units per week) to medical institutions in Japan.
  • Donation of approximately 110,000 medical masks and approximately 400,000 surgical masks in Japan.
  • Donations for medical professionals and others who are working to combat COVID-19 through Hitachi's benefit plan in Japan.
  • Provision of 1 million U.S. dollars in loans through Kiva to businesses in need around the globe, affected by the spread of the COVID-19

Want more of the latest science news straight to your inbox? Become a SelectScience member for free today>>

Links

Hitachi High Technologies America, Inc.Company website

Tags

AntibodiesAntibodies are used in techniques such as confocal and fluorescence microscopy, flow cytometry, ELISA, ELISPOT, immunohistochemistry, western blotting and immunopreciptation. Select specific antigen reactivity, high specific affinity, low non-specific binding, monoclonal or polyclonal, primary or secondary antibodies and associated conjugates such as an enzyme or dye for visualization.BiomarkersBiomarkers are biological markers which can be measured and evaluated to indicate a biological state. The use of biomarkers in research and diagnosis can indicate a normal or disease state or drug response of cells / tissues. Biomarkers include genetic markers, cell surface markers such as antigens, antibodies or receptors and secreted molecules such as cytokines. An assay system is required for identification of biomarkers. :CoronavirusCoronaviruses are a large family of viruses that can cause illnesses ranging from the common cold to more severe diseases like COVID-19. Research into the biology, transmission, and treatment of coronaviruses has become a global priority, particularly since the emergence of SARS-CoV-2. Understanding the virus�s structure and behavior is essential for developing vaccines, diagnostics, and antiviral treatments. Explore our peer-reviewed product directory to discover the latest research tools, diagnostic tests, vaccines, and treatments for coronavirus, compare products, read reviews, and receive pricing directly from manufacturers.Covid-19COVID-19, caused by the SARS-CoV-2 virus, has led to a global health crisis with profound impacts on societies and economies. Research into diagnostics, vaccines, treatments, and understanding viral mechanisms continues to evolve. The pandemic has accelerated innovations in healthcare and biopharmaceuticals, including novel vaccine platforms and rapid testing technologies. Browse our peer-reviewed product directory to find top COVID-19 testing kits, research tools, vaccines, and treatments, compare products, read reviews, and receive direct pricing from manufacturers.Infectious DiseasesInfectious diseases are caused by pathogens such as bacteria, viruses, and fungi. Effective detection, prevention, and treatment are crucial to control outbreaks and improve public health. Diagnostic tools, vaccines, and antimicrobial treatments are essential components of managing these diseases. Research into emerging pathogens and resistance patterns continues to evolve. Browse our peer-reviewed product directory to find the best diagnostic tools, prevention solutions, and treatment options; compare products, read customer reviews, and get pricing directly from manufacturers.

Related articles

Hitachi to support researches in infectious diseases through the Hitachi Global Foundation